Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis

Annals of Oncology

Volumn 17, Issue 8, 2006, Pages 1255-1262

  Zell, J A ^a,b   Ou, S H I ^a,b   Ziogas, A ^a,b   Anton Culver, H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bronchiolo alveolar carcinoma, (BAC); Epidemology; Staging; Survival

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNOLOGY; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; LUNG ALVEOLUS CELL CARCINOMA; LUNG LOBE; LUNG METASTASIS; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME;

EID: 33748174235     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl121     Document Type: Article

References (33)

1. Barkley JE, Green MR. Bronchioloalveolar carcinoma. J Clin Oncol 1996; 14: 2377-2386.
2. Barsky SH, Cameron R, Osann KE et al. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer 1994; 73: 1163-1170.
3. Breathnach OS, Ishibe N, Williams J et al. Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung. Cancer 1999; 86: 1165-1173.
4. Lee KS, Kim Y, Han J, Ko EJ et al. Bronchioloalveolar carcinoma: clinical histopathologic, and radiologic findings. Radiographics 1997; 17: 1345-1357.
5. Mirtcheva RM, Vasquez M, Yankelevitz DF, Henschke CI. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT. Clinical Imaging 2002; 26: 95-100.
6. Read WL, Page NC, Tierney RM et al. The Epidemiology of bronchioloalveolar carcinoma over the past two decades: Analysis of the SEER Database. Lung Cancer 2004; 45(2): 137-142.
7. Ebright MI, Zakowski MF, Martin J et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Annals Thoracic Surgery 2002; 74: 1640-1647.
8. Travis WD, Garg K, Franklin WA et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005; 23(14): 3279-87.
9. Mountain CF. Revisions in the international system for staging lung cancer. chest 1997; 111: 1710-1717.
10. Greene FL, Page DL, Fleming ID et al. AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 6th ed., Springer-Verlag, New York, Springer-Verlag; 2002.
11. Roberts PF, Straznicka M, Lara PN et al. Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved. J Thorac Cardiovasc Surg 2003; 126: 1597-1602.
12. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Public-Use Data (1973-2002). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission. 2005.
13. ICD-9-CM: International Classification of Diseases, 9th revision, Clinical Modification, fifth edition, color coded, Volumes 1, 2 and 3, 5th edn. Los Angeles: Practice Management Information Corp.; 1997.
14. Battafarano RJ, Meyers BF, Guthrie TJ et al. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival. Annal Thorac Surg 2002; 74: 988-993.
15. Volpino P, D'Andrea N, Cangemi R et al. Bronchioloalveolar carcinoma: clinical, radiographic, and pathological findings-surgical results. J Cardiovasc Surg 2001; 42: 261-267.
16. Zell JA, Ou SHI, Ziogas A, Anton-Culver H. Epidemiology of bronchioloalveolar carcinoma: Improvement in survival after release of the 1999 WHO Classification of Lung Tumors. J Clin Oncol 2005; 23: 8396-8405.
17. Travis WD, Colby TV, Corrin B, and in Collaboration with Sobin LH and Pathologists from 14 Countries, World Health Organization International Histological Classification of Tumours. Histological Typing of Lung and Plueral Tumours. 3rd edn. Springer-Verlag; 1999.
18. Noguchi M, Morikawa A, Kawasaki M et al. Small adenocarcinoma of the lung - histologic characteristics and prognosis. cancer 1995; 75(12): 2844-52.
19. Castro CY, Coffey DM, Medeiros LJ, Cagle PT. Prognostic significance of percentage of bronchioloalveolar Pattern in adenocarcinomas of the lung. Ann Diagn Pathol 2001; 5: 274-284.
20. Daly RC, Trastek VF, Pairolero PC et al. Bronchoalveolar carcinoma: factors affecting survival. Ann Thorac Surg 1991; 51: 368-376.
21. Field RW, Smith BJ, Platz CE et al. Lung cancer histologic type in the surveillance, Epidemiology, and End results registry versus Independent review. J Natl Cancer Inst 2004; 96: 1105-1107.
22. Henson DE, Albores-Saavedra J. Checking up on the surveillance, epidemiology, and end results program. J Natl Cancer Inst 2004; 96: 1050-1051.
23. Tosi P, Sforza V, Santopietro R et al. Bronchioloalveolar carcinoma - An analysis of survival predictors. Eur J Cancer 1992; 28A: 1365-1370.
24. Volpino P, Cavallaro A, Cangemi R et al. Comparative analysis of clinical features and prognostic factors in resected bronchioloalveolar carcinoma and adenocarcinoma of the lung. Anticancer Res 2003; 23: 4959-4965.
25. Hasan S, Mujahid H, Yousef M, Chisholm R. Bronchioloalveolar carcinoma in African Americans. J Natl Med Assoc 2004; 96: 1193-1198.
26. Alberg AJ, Brock MV, Samet JM. Epidemiology of Lung Cancer: Looking to the future. J Clin Oncol 2005; 23: 3175-3185.
27. Jemal A, Murray T, Ward E et al. Cancer Statistics 2005; Ca-A Cancer J Clin 2005; 55: 10-30.
28. US Cancer Statistics Working Group. United States Cancer Statistics: 2001 incidence and mortality. Atlanta, GA, US Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. 2004.
29. Fujisawa T, Lizasa T, Saitoh Y et al. Smoking before surgery predicts poor long-term survival in patients With stage I non-small-cell lung carcinomas. J Clin Oncol 1999; 17(7): 2086-91.
30. Nia PS, Weyler J, Colpaert C et al. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer 2005; 47: 351-359.
31. Nordquist LT, Simon GR, Cantor A et al. Improved survival in never-smokers vs. current smokers with primary adenocarcinoma of the lung. Chest 2004; 126: 347-351.
32. Sioris T, Husgafvel-Pursiainen K, Karjalainen A et al. Survival, in operable non-small-cell lung cancer: Role of P53 mutations, Tobacco smoking and asbestos exposure. Int J Cancer 2000; 86: 590-594.
33. Cohen MH, Williams GA, Sridhara R et al. United States Food and Drug Administration Drug Approval Summary: Gefitinib (ZD1839; Iressa) tablets. Clin Cancer Res 2004; 10: 1212-1218.